Purpose Screening is a major contributor to colorectal cancer (CRC) mortality reductions in
the United States but is underused. We estimated the fraction of CRC deaths attributable to …

Background & Aims The American Cancer Society has recommended initiating colorectal
cancer (CRC) screening at age 45 years instead of 50 years. We estimated the cost …

Background & Aims Delays in diagnostic testing after a positive result from a screening test
can undermine the benefits of colorectal cancer (CRC) screening, but there are few …

ContextA recent expert panel recommended that persons at average risk of colorectal
cancer (CRC) begin screening for CRC at age 50 years using 1 of several strategies …

Importance Colorectal cancer is the second leading cause of cancer death in the United
States. In 2016, an estimated 134 000 persons will be diagnosed with the disease, and …

Background & Aims: Colorectal cancer (CRC) screening is effective and cost-effective, but
the potential national impact of widespread screening is uncertain. It is controversial whether …

Background Colorectal cancer (CRC) fulfills the World Health Organization criteria for mass
screening, but screening uptake is low in most countries. CRC screening is resource …

This document is a focused update to the 2017 colorectal cancer (CRC) screening
recommendations from the US Multi-Society Task Force on Colorectal Cancer, which …

Background Colorectal cancer (CRC) screening with colonoscopy and the fecal
immunochemical test (FIT) is underused. Innovative tests could increase screening …

Background: It is strongly recommended that adults aged 50–75 years be screened for
colorectal cancer. Recommended screening options include colonoscopy, sigmoidoscopy …